Literature DB >> 15669029

The quest for quinine: those who won the battles and those who won the war.

Teodoro S Kaufman1, Edmundo A Rúveda.   

Abstract

For a long time, the synthesis of quinine constituted an elusive target. In 2004, which marked the 60th anniversary of the publication of the approach used by Woodward and Doering to synthesize quinine, two new stereocontrolled total syntheses of the natural product were accomplished. Together with the well-publicized first stereocontrolled total synthesis of quinine by Stork in 2001, these publications evidence the revival of interest of organic chemists in the synthesis of this compound, once considered a miracle drug. The recently disclosed syntheses of quinine also testify in a remarkable manner the huge progress made by organic synthesis during the last three decades since the first series of partially controlled syntheses of quinine by the group of Uskokovic. Following an account of the historical importance of quinine as an antimalarial drug and a brief description of the experiments which contributed to its isolation and structural elucidation, the first reconstructions of quinine and the total syntheses of the natural product are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15669029     DOI: 10.1002/anie.200400663

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  23 in total

Review 1.  Salinosporamide natural products: Potent 20 S proteasome inhibitors as promising cancer chemotherapeutics.

Authors:  Tobias A M Gulder; Bradley S Moore
Journal:  Angew Chem Int Ed Engl       Date:  2010-12-03       Impact factor: 15.336

Review 2.  Hemozoin biocrystallization in Plasmodium falciparum and the antimalarial activity of crystallization inhibitors.

Authors:  Ernst Hempelmann
Journal:  Parasitol Res       Date:  2006-11-17       Impact factor: 2.289

Review 3.  Bright ideas for chemical biology.

Authors:  Luke D Lavis; Ronald T Raines
Journal:  ACS Chem Biol       Date:  2008-03-20       Impact factor: 5.100

4.  Rabe rest in peace: confirmation of the rabe-kindler conversion of D-quinotoxine into quinine: experimental affirmation of the Woodward-Doering formal total synthesis of quinine.

Authors:  Aaron C Smith; Robert M Williams
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

5.  Accelerating the semisynthesis of alkaloid-based drugs through metabolic engineering.

Authors:  Amy M Ehrenworth; Pamela Peralta-Yahya
Journal:  Nat Chem Biol       Date:  2017-02-15       Impact factor: 15.040

6.  Structure-based discovery of natural-product-like TNF-α inhibitors.

Authors:  Daniel Shiu-Hin Chan; Ho-Man Lee; Fang Yang; Chi-Ming Che; Catherine C L Wong; Ruben Abagyan; Chung-Hang Leung; Dik-Lung Ma
Journal:  Angew Chem Int Ed Engl       Date:  2010-03-16       Impact factor: 15.336

7.  Intermolecular radical addition to N-acylhydrazones as a stereocontrol strategy for alkaloid synthesis: formal synthesis of quinine.

Authors:  Gregory K Friestad; An Ji; Chandra Sekhar Korapala; Jun Qin
Journal:  Org Biomol Chem       Date:  2011-05-03       Impact factor: 3.876

8.  Concise stereocontrolled formal synthesis of (+/-)-quinine and total synthesis of (+/-)-7- hydroxyquinine via merged Morita-Baylis-Hillman-Tsuji-Trost cyclization.

Authors:  Peter Webber; Michael J Krische
Journal:  J Org Chem       Date:  2008-12-05       Impact factor: 4.354

9.  Accurate mass-time tag library for LC/MS-based metabolite profiling of medicinal plants.

Authors:  Daniel J Cuthbertson; Sean R Johnson; Jasenka Piljac-Žegarac; Julia Kappel; Sarah Schäfer; Matthias Wüst; Raymond E B Ketchum; Rodney B Croteau; Joaquim V Marques; Laurence B Davin; Norman G Lewis; Megan Rolf; Toni M Kutchan; D Doel Soejarto; B Markus Lange
Journal:  Phytochemistry       Date:  2013-04-16       Impact factor: 4.072

10.  A Survey of Solvents for the Conrad-Limpach Synthesis of 4-Hydroxyquinolones.

Authors:  Jean-Cristophe Brouet; Shen Gu; Norton P Peet; John D Williams
Journal:  Synth Commun       Date:  2009-01-01       Impact factor: 2.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.